Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1066 AL 1080

PINK1 and Parkin: emerging themes in mitochondrial homeostasis

McWilliams TG, Muqit MM.

Curr Opin Cell Biol. 2017 Apr;45:83-91. doi: 10.1016/j.ceb.2017.03.013. Epub 2017 Apr 22.

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study

Benn M, Nordestgaard BG, Frikke-Schmidt R, Tybjærg-Hansen A.

BMJ. 2017 Apr 24;357:j1648. doi: 10.1136/bmj.j1648.

Brain metabolism in health, aging, and neurodegeneration

Camandola S, Mattson MP.

EMBO J. 2017 Jun 1;36(11):1474-1492. doi: 10.15252/embj.201695810. Epub 2017 Apr 24.

Training dual tasks together or apart in Parkinson's disease: Results from the DUALITY trial

Strouwen C, Molenaar EALM, Münks L, Keus SHJ, Zijlmans JCM, Vandenberghe W, Bloem BR, Nieuwboer A.

Mov Disord. 2017 Aug;32(8):1201-1210. doi: 10.1002/mds.27014. Epub 2017 Apr 25.

[Tumors of the central nervous system]

Alegría-Loyola MA, Galnares-Olalde JA, Mercado M.

Rev Med Inst Mex Seguro Soc. 2017 May-Jun;55(3):330-340.

Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration

Stockwell J, Jakova E, Cayabyab FS.

Molecules. 2017 Apr 23;22(4):676. doi: 10.3390/molecules22040676.

Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP

Schildknecht S, Di Monte DA, Pape R, Tieu K, Leist M.

Trends Pharmacol Sci. 2017 Jun;38(6):541-555. doi: 10.1016/j.tips.2017.03.010. Epub 2017 Apr 23.

Clinical evaluation of ropinirole controlled-release formulation at 18-24 mg/day in Japanese patients with Parkinson's disease

Hattori N, Hasegawa K, Sato K, Mitsuyama E, Numachi Y.

Parkinsonism Relat Disord. 2017 Jul;40:33-39. doi: 10.1016/j.parkreldis.2017.04.005. Epub 2017 Apr 13.

The effect of active video games on cognitive functioning in clinical and non-clinical populations: A meta-analysis of randomized controlled trials

Stanmore E, Stubbs B, Vancampfort D, de Bruin ED, Firth J.

Neurosci Biobehav Rev. 2017 Jul;78:34-43. doi: 10.1016/j.neubiorev.2017.04.011. Epub 2017 Apr 23.

Targeting LRRK2 in Parkinson's disease: an update on recent developments

Chan SL, Tan EK.

Expert Opin Ther Targets. 2017 Jun;21(6):601-610. doi: 10.1080/14728222.2017.1323881. Epub 2017 May 15.

The Leukocentric Theory of Neurological Disorder: A Manifesto

Fern R.

Neurochem Res. 2017 Sep;42(9):2666-2672. doi: 10.1007/s11064-017-2279-8. Epub 2017 Apr 25.

Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA

Guhathakurta S, Bok E, Evangelista BA, Kim YS.

Prog Neurobiol. 2017 Jul;154:21-36. doi: 10.1016/j.pneurobio.2017.04.004. Epub 2017 Apr 23.

Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes

Scott L, Dawson VL, Dawson TM.

Exp Neurol. 2017 Dec;298(Pt B):191-201. doi: 10.1016/j.expneurol.2017.04.008. Epub 2017 Apr 23.

Balance training in individuals with Parkinson's disease: Therapist-supervised vs. home-based exercise programme

Atterbury EM, Welman KE.

Gait Posture. 2017 Jun;55:138-144. doi: 10.1016/j.gaitpost.2017.04.006. Epub 2017 Apr 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias